June 19, 2015
Cheaper Substitute for Lucentis Developed in India
Intas Pharmaceuticals, a company based in India, has launched RAZUMABâ„¢, an anti-VEGF drug that is “biosimilar” to Lucentis. This means that RAZUMAB has a synthesized chemical structure that can substitute for, but not duplicate, Lucentis. To make biosimilarity possible, scientists must show that the new product is highly similar and have no significant differences from […]